Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Obese Population
4.2.2 Prevalence of Diabetes and Heart Diseases
4.3 Market Restraints
4.3.1 Lack of Knowledge and awareness in Developing and Underdeveloped Nations
4.3.2 High Cost of surgery
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION (Market Size by Value – USD million)
5.1 By Device Type
5.1.1 Assisting Devices
5.1.2 Implantable Devices
5.2 By End User
5.2.1 Bariatric Surgery Clinics
5.2.2 Hospitals
5.2.3 Ambulatory Surgical Centers
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Apollo Endosurgery Inc
6.1.2 Johnson& Johnson
6.1.3 TransEnterrix Inc
6.1.4 Allergenc, Inc
6.1.5 ReShape Medical, Inc
6.1.6 Medtronic Plc
6.1.7 Entero Medica, Inc
6.1.8 Aspire Bariatrics Inc


7 MARKET OPPORTUNITIES AND FUTURE TRENDS